According to findings from a recent study by MindMed, a biopharmaceutical company specializing in brain health disorders, a single dose of LSD can significantly reduce anxiety within weeks.
MindMed disclosed these breakthrough results on Friday, revealing that just 100 micrograms of MM120, the salt form of lysergide d-tartrate (LSD), provided sustained relief for individuals with generalized anxiety disorder (GAD).
GAD is characterized by persistent and excessive worry about everyday matters, leading to fear, chronic anxiety, and a sense of being overwhelmed. Currently, approximately 10% of US adults, roughly 20 million individuals, are affected by this disorder.
The study found that a single dose of 100 micrograms of MM120 resulted in a 48% remission rate from GAD after 12 weeks.
Although some participants reported mild to moderate side effects such as euphoria, illusions, hallucinations, anxiety, headaches, dizziness, nausea, sweating, vomiting, skin numbness or tingling, and pupil dilation on the day of dosing, the drug still needs to undergo the standard FDA approval process and will proceed to phase III trials soon.
Additionally, the study revealed rapid and significant improvement in depression symptoms among participants, as depression and anxiety often share overlapping characteristics. Approximately 65% of patients experienced improvement within three months.
